Government inks agreement to buy 5.6 crore vaccine doses from Serum Institute of India


Symbolic picture

new Delhi:

The ongoing war from Corona is now reaching a decisive phase in the country. The effort of the government to deliver vaccine to the common people has intensified. On Monday, HLL Life Care Limited (a Government of India venture), on behalf of the Government of India, has purchased the vaccine from Serum Institute of India and has signed an agreement to purchase more. It has also been committed to buy 4.5 crore doses and Rs 200 per dose by April 2021. India has so far signed an agreement to purchase 5.6 crore vaccine doses from the Siram Institute alone.

Also read

Official sources said that the government has committed to buy 4.5 crore vaccines by April. This entire order will cost more than Rs 1100 crore. He told that sending vaccines is expected to start early Tuesday. According to the order given, each “Kovishield” vaccine will cost Rs 210 including Rs 200 and Rs 10 GST.

Meanwhile, Prime Minister Narendra Modi on Monday announced that the central government will bear the cost of vaccination of three crore people, health workers and front line employees in the first phase of Corona vaccination campaign. Also, he clarified that the public representatives will not be included in this phase. Prior to the upcoming nationwide vaccination campaign starting from January 16, the Prime Minister today interacted with the Chief Ministers of all the states and said that vaccination for Kovid-19 has been going on in the last three-four weeks in about 50 countries and till now only 2.5 crores People have been vaccinated while India aims to vaccinate 300 million people in the next few months. Modi also said that both the Corona vaccines prepared in the country are cheaper than other vaccines in the world and they have been manufactured according to the conditions and conditions of the country. In view of the questions arising on vaccines, the Prime Minister assured that the scientific community has taken “all precautions” to give the countrymen an “effective” vaccine.

He said that the country is now entering the decisive phase of the war against Corona. The Kovid-19 vaccine ‘Kovishield’ from Oxford and Bharat Biotech’s indigenously developed vaccine ‘Kovaxin’ manufactured by the Serum Institute of India were approved by the Drug Regulator of India for limited emergency use in the country. . In his address, the Prime Minister said that dialogue and cooperation between the Center and the States have played a huge role in the fight against Corona and this is a great example of cooperative federalism. He said that the nervousness and anxiety he had in the countrymen seven-eight months ago, he has now exited. He described it as a “good situation” for the country and warned that despite this, carelessness should not be taken. He said, “The effect of increasing trust in the countrymen is also showing positive effects on economic activities.” Now our country is entering a decisive phase in the fight against Corona. This is the phase of vaccination. From January 16, we are starting the world’s largest vaccination campaign. ”


The Prime Minister said that it is a matter of pride for the country that the two vaccines that have been approved for emergency use are both “Made in India”. Modi said that not only this, work is being done on four more vaccines. When these vaccines come, we will have more facility to plan for the future. He said, “Both our vaccines are more economical than the second vaccine in the world.” We can imagine what would have happened if India had to depend on foreign vaccine for the Corona vaccine. We can guess how difficult it is. This vaccine has been created keeping in view the conditions and circumstances of India.

(Also from input language)


Please enter your comment!
Please enter your name here